Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,503 | -38,626 | 7,509 | 34,590 | 46,885 |
| Depreciation Amortization | 2,029 | 8,356 | 6,268 | 4,173 | 2,048 |
| Accounts receivable | 7,000 | -7,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,377 | -13,708 | -3,096 | -11,976 | -10,874 |
| Other Working Capital | 141 | -9,189 | -5,826 | -127,342 | -98,635 |
| Other Operating Activity | -6,413 | 37,369 | 15,361 | 20,343 | 15,084 |
| Operating Cash Flow | $-37,369 | $-22,798 | $20,216 | $-80,212 | $-45,492 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -259,129 | -97,133 | -32,834 | -71,623 | -98,642 |
| PPE Investments | -1,868 | -4,700 | -3,933 | -3,282 | -1,587 |
| Investing Cash Flow | $-260,997 | $-101,833 | $-36,767 | $-74,905 | $-100,229 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 328,822 | 30,708 | 727 | 379 | 14 |
| Other Financing Activity | -487 | -357 | 0 | 0 | 0 |
| Financing Cash Flow | $328,335 | $30,351 | $727 | $379 | $14 |
| Beginning Cash Position | 134,837 | 229,117 | 229,117 | 229,117 | 229,117 |
| End Cash Position | 164,806 | 134,837 | 213,293 | 74,379 | 83,410 |
| Net Cash Flow | $29,969 | $-94,280 | $-15,824 | $-154,738 | $-145,707 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,369 | -22,798 | 20,216 | -80,212 | -45,492 |
| Capital Expenditure | -1,868 | -4,700 | -3,933 | -3,282 | -1,587 |
| Free Cash Flow | -39,237 | -27,498 | 16,283 | -83,494 | -47,079 |